Literature DB >> 8755529

Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.

M Grano1, F Galimi, G Zambonin, S Colucci, E Cottone, A Z Zallone, P M Comoglio.   

Abstract

Hepatocyte growth factor (HGF), also known as scatter factor, is a powerful motogen, mitogen, and morphogen produced by cells of mesodermal origin, acting on epithelial and endothelial cells. Its receptor is the tyrosine kinase encoded by the c-MET protooncogene. We show that the HGF receptor is expressed by human primary osteoclasts, by osteoclast-like cell lines, and by osteoblasts. In both cell lineages, HGF stimulation triggers the receptor kinase activity and autophosphorylation. In osteoclasts, HGF receptor activation is followed by increase in intracellular Ca2+ concentration and by activation of the pp60c-Src kinase. HGF induces changes in osteoclast shape and stimulates chemotactic migration and DNA replication. Osteoblasts respond to HGF by entering the cell cycle, as indicated by stimulation of DNA synthesis. Interestingly, osteoclasts were found to synthesize and secrete biologically active HGF. These data strongly suggest the possibility of an autocrine regulation of the osteoclast by HGF and a paracrine regulation of the osteoblast by the HGF produced by the osteoclast.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755529      PMCID: PMC38800          DOI: 10.1073/pnas.93.15.7644

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Association between the PDGF receptor and members of the src family of tyrosine kinases.

Authors:  R M Kypta; Y Goldberg; E T Ulug; S A Courtneidge
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

Review 2.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 3.  Role of transforming growth factor-beta in bone remodeling.

Authors:  L F Bonewald; G R Mundy
Journal:  Clin Orthop Relat Res       Date:  1990-01       Impact factor: 4.176

4.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

5.  Molecular cloning and expression of human hepatocyte growth factor.

Authors:  T Nakamura; T Nishizawa; M Hagiya; T Seki; M Shimonishi; A Sugimura; K Tashiro; S Shimizu
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

6.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

7.  Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane.

Authors:  H Takemura; A R Hughes; O Thastrup; J W Putney
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

8.  Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement.

Authors:  E Gherardi; J Gray; M Stoker; M Perryman; R Furlong
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

10.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.

Authors:  K M Weidner; J Behrens; J Vandekerckhove; W Birchmeier
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

View more
  55 in total

Review 1.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 3.  Bone cell communication factors and Semaphorins.

Authors:  Takako Negishi-Koga; Hiroshi Takayanagi
Journal:  Bonekey Rep       Date:  2012-09-19

4.  Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.

Authors:  Jiaqi Mi; Erika Hooker; Steven Balog; Hong Zeng; Daniel T Johnson; Yongfeng He; Eun-Jeong Yu; Huiqing Wu; Vien Le; Dong-Hoon Lee; Joseph Aldahl; Mark L Gonzalgo; Zijie Sun
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

5.  Mechanisms of osteoclast-dependent bone formation.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2013-12-04

6.  Cabozantinib as a novel therapy for renal cell carcinoma.

Authors:  Ulka Vaishampayan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

7.  Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.

Authors:  David C Smith; Matthew R Smith; Christopher Sweeney; Aymen A Elfiky; Christopher Logothetis; Paul G Corn; Nicholas J Vogelzang; Eric J Small; Andrea L Harzstark; Michael S Gordon; Ulka N Vaishampayan; Naomi B Haas; Alexander I Spira; Primo N Lara; Chia-Chi Lin; Sandy Srinivas; Avishay Sella; Patrick Schöffski; Christian Scheffold; Aaron L Weitzman; Maha Hussain
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

8.  Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.

Authors:  Larry Pederson; Ming Ruan; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

9.  Association of KIT gene polymorphisms with bone mineral density in postmenopausal Korean women.

Authors:  Shin-Yoon Kim; Jong-Young Lee; Ha Young Kim; Bermseok Oh; Kuchan Kimm; Hyung-Lae Kim; Byung Lae Park; Hyoung Doo Shin; Eui Kyun Park; Jung-Min Koh; Ghi Su Kim
Journal:  J Hum Genet       Date:  2007-05-09       Impact factor: 3.172

Review 10.  Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer.

Authors:  Richard J Lee; Matthew R Smith
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.